Gene expression studies can also involve looking at profiles or patterns of expression of several genes.听RNA sequencing听(RNA-Seq) leverages the advantages of听next-generation sequencing听(NGS) to detect and quantify听RNA听in a biological sample at a given point in time.
Market Analysis and Insights: Global NGS-based RNA-sequencing Market
The global NGS-based RNA-sequencing market is projected to grow from US$ 3000 million in 2024 to US$ 7862.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 17.4% during the forecast period.
A significant driver in the NGS-based RNA-sequencing market is the increasing demand for comprehensive and high-throughput analysis of RNA molecules for research and clinical applications. Next-generation sequencing (NGS) technology enables researchers to examine gene expression, identify alternative splicing events, and detect RNA modifications at an unprecedented scale. However, a notable challenge in this market is the need for data analysis and storage solutions. Managing the vast amount of data generated by NGS-based RNA-sequencing while ensuring data accuracy, security, and accessibility poses a significant challenge. Bioinformatics tools, cloud-based solutions, and data management strategies must be continually developed to streamline data analysis and storage processes, facilitating the broader adoption of NGS-based RNA-sequencing in genomics research and precision medicine.
Report Covers:
This report presents an overview of global market for NGS-based RNA-sequencing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of NGS-based RNA-sequencing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for NGS-based RNA-sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the NGS-based RNA-sequencing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global NGS-based RNA-sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for NGS-based RNA-sequencing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Segment by Application
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of NGS-based RNA-sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NGS-based RNA-sequencing companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NGS-based RNA-sequencing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sequencing by Synthesis
1.2.3 Ion Semiconductor Sequencing
1.2.4 Single-molecule Real-time Sequencing
1.2.5 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Research & Academia
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-sequencing Market Perspective (2019-2030)
2.2 Global NGS-based RNA-sequencing Growth Trends by Region
2.2.1 NGS-based RNA-sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 NGS-based RNA-sequencing Historic Market Size by Region (2019-2024)
2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Region (2025-2030)
2.3 NGS-based RNA-sequencing Market Dynamics
2.3.1 NGS-based RNA-sequencing Industry Trends
2.3.2 NGS-based RNA-sequencing Market Drivers
2.3.3 NGS-based RNA-sequencing Market Challenges
2.3.4 NGS-based RNA-sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue NGS-based RNA-sequencing by Players
3.1.1 Global NGS-based RNA-sequencing Revenue by Players (2019-2024)
3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2019-2024)
3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of NGS-based RNA-sequencing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2023
3.5 Global Key Players of NGS-based RNA-sequencing Head office and Area Served
3.6 Global Key Players of NGS-based RNA-sequencing, Product and Application
3.7 Global Key Players of NGS-based RNA-sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-sequencing Breakdown Data by Type
4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2019-2024)
4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2025-2030)
5 NGS-based RNA-sequencing Breakdown Data by Application
5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2019-2024)
5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America NGS-based RNA-sequencing Market Size (2019-2030)
6.2 North America NGS-based RNA-sequencing Market Size by Type
6.2.1 North America NGS-based RNA-sequencing Market Size by Type (2019-2024)
6.2.2 North America NGS-based RNA-sequencing Market Size by Type (2025-2030)
6.2.3 North America NGS-based RNA-sequencing Market Share by Type (2019-2030)
6.3 North America NGS-based RNA-sequencing Market Size by Application
6.3.1 North America NGS-based RNA-sequencing Market Size by Application (2019-2024)
6.3.2 North America NGS-based RNA-sequencing Market Size by Application (2025-2030)
6.3.3 North America NGS-based RNA-sequencing Market Share by Application (2019-2030)
6.4 North America NGS-based RNA-sequencing Market Size by Country
6.4.1 North America NGS-based RNA-sequencing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America NGS-based RNA-sequencing Market Size by Country (2019-2024)
6.4.3 North America NGS-based RNA-sequencing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe NGS-based RNA-sequencing Market Size (2019-2030)
7.2 Europe NGS-based RNA-sequencing Market Size by Type
7.2.1 Europe NGS-based RNA-sequencing Market Size by Type (2019-2024)
7.2.2 Europe NGS-based RNA-sequencing Market Size by Type (2025-2030)
7.2.3 Europe NGS-based RNA-sequencing Market Share by Type (2019-2030)
7.3 Europe NGS-based RNA-sequencing Market Size by Application
7.3.1 Europe NGS-based RNA-sequencing Market Size by Application (2019-2024)
7.3.2 Europe NGS-based RNA-sequencing Market Size by Application (2025-2030)
7.3.3 Europe NGS-based RNA-sequencing Market Share by Application (2019-2030)
7.4 Europe NGS-based RNA-sequencing Market Size by Country
7.4.1 Europe NGS-based RNA-sequencing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe NGS-based RNA-sequencing Market Size by Country (2019-2024)
7.4.3 Europe NGS-based RNA-sequencing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China NGS-based RNA-sequencing Market Size (2019-2030)
8.2 China NGS-based RNA-sequencing Market Size by Type
8.2.1 China NGS-based RNA-sequencing Market Size by Type (2019-2024)
8.2.2 China NGS-based RNA-sequencing Market Size by Type (2025-2030)
8.2.3 China NGS-based RNA-sequencing Market Share by Type (2019-2030)
8.3 China NGS-based RNA-sequencing Market Size by Application
8.3.1 China NGS-based RNA-sequencing Market Size by Application (2019-2024)
8.3.2 China NGS-based RNA-sequencing Market Size by Application (2025-2030)
8.3.3 China NGS-based RNA-sequencing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia NGS-based RNA-sequencing Market Size (2019-2030)
9.2 Asia NGS-based RNA-sequencing Market Size by Type
9.2.1 Asia NGS-based RNA-sequencing Market Size by Type (2019-2024)
9.2.2 Asia NGS-based RNA-sequencing Market Size by Type (2025-2030)
9.2.3 Asia NGS-based RNA-sequencing Market Share by Type (2019-2030)
9.3 Asia NGS-based RNA-sequencing Market Size by Application
9.3.1 Asia NGS-based RNA-sequencing Market Size by Application (2019-2024)
9.3.2 Asia NGS-based RNA-sequencing Market Size by Application (2025-2030)
9.3.3 Asia NGS-based RNA-sequencing Market Share by Application (2019-2030)
9.4 Asia NGS-based RNA-sequencing Market Size by Region
9.4.1 Asia NGS-based RNA-sequencing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia NGS-based RNA-sequencing Market Size by Region (2019-2024)
9.4.3 Asia NGS-based RNA-sequencing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Type
10.2.1 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Application
10.3.1 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Country
10.4.1 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-sequencing Introduction
11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.1.5 Illumina Recent Developments
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Details
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.2.5 Thermo Fischer Scientific Recent Developments
11.3 Oxford Nanopore
11.3.1 Oxford Nanopore Company Details
11.3.2 Oxford Nanopore Business Overview
11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.3.5 Oxford Nanopore Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.4.5 Agilent Technologies Recent Developments
11.5 BGI
11.5.1 BGI Company Details
11.5.2 BGI Business Overview
11.5.3 BGI NGS-based RNA-sequencing Introduction
11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.5.5 BGI Recent Developments
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.6.5 PerkinElmer Recent Developments
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN NGS-based RNA-sequencing Introduction
11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.7.5 QIAGEN Recent Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.8.5 Eurofins Scientific Recent Developments
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche NGS-based RNA-sequencing Introduction
11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.9.5 Roche Recent Developments
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio NGS-based RNA-sequencing Introduction
11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.10.5 Takara Bio Recent Developments
11.11 GENEWIZ
11.11.1 GENEWIZ Company Details
11.11.2 GENEWIZ Business Overview
11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.11.5 GENEWIZ Recent Developments
11.12 Hamilton
11.12.1 Hamilton Company Details
11.12.2 Hamilton Business Overview
11.12.3 Hamilton NGS-based RNA-sequencing Introduction
11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.12.5 Hamilton Recent Developments
11.13 Macrogen
11.13.1 Macrogen Company Details
11.13.2 Macrogen Business Overview
11.13.3 Macrogen NGS-based RNA-sequencing Introduction
11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.13.5 Macrogen Recent Developments
11.14 Zymo Research
11.14.1 Zymo Research Company Details
11.14.2 Zymo Research Business Overview
11.14.3 Zymo Research NGS-based RNA-sequencing Introduction
11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.14.5 Zymo Research Recent Developments
11.15 Tecan Genomics
11.15.1 Tecan Genomics Company Details
11.15.2 Tecan Genomics Business Overview
11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.15.5 Tecan Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
听
听
*If Applicable.
